Sidebar is Loading...
Loading...
Brands
Resources
YSTV
ADVERTISEMENT
Loading...
Brands
Resources
YSTV
Aimorphous Health (AH) AG, a Swiss med tech startup, is developing a cutting-edge AI-powered blood diagnostic device, which will provide the state-of-the-art diagnostics and prediction of thrombosis and bleeding risks.
Aimorphous Health (AH) AG, a Swiss med tech startup, is developing a cutting-edge AI-powered blood diagnostic device, which will provide the state-of-the-art diagnostics and prediction of thrombosis and bleeding risks. The technology is developed based on a patented novel biomarker developed by AH which reveals day-to-day changes in the risks. Their mission is the development of an advanced AI-powered medical device with the primary objective of mitigating fatalities associated with blood clots occurring in conditions such as strokes and heart attacks.
Headquarters
:
Basel, Basel-Stadt, Switzerland
Founding Date
:
2022
No. of Employees
:
<10
Core Team
:
1.
Daniel Shoukier
Co-Founder
2.
San Pun
Chief Executive Officer
Frequently Asked Questions
